18
2020 Q1 CORPORATE PRESENTATION AleafiaHealth.com Confidential & Proprietary 1

2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

  • Upload
    others

  • View
    16

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

2 0 2 0 Q 1 C O R P O R AT E P R E S E N TAT I O N

AleafiaHealth.com

Confidential & Proprietary 1

Page 2: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

Certain statements herein relating to the Company constitute “forward looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or

objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward-looking statements”. Such “forward-looking statements involve unknown risks and uncertainties that

could cause actual and future events to differ materially from those anticipated in such statements. Forwardlooking statements include, but are not limited to, statements with respect to commercial operations, including production and/

or sales of marijuana, quantities of future marijuana production, anticipated revenues in connection with such sales, the overall projected size of the market, completion and/or expansion of production facilities, and other Information

that is based on forecasts of future results, estimates of production not yet determinable, and other key management assumptions. Actual results may differ materially from those expressed or implied by such forwardlooking statements

and involve risk and uncertainties relating to the Company’s historical experience with regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in marijuana prices, actual operating performance

of facilities , and other uninsured risks. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Contents are provided for general information

purposes only and do not constitute an offer to sell or solicitation of an offer to buy any security in any jurisdiction

2Confidential & Proprietary

Page 3: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

ScienceData analytics and science-based medicine

informs every decision, from strains to treatment. If it matters, measure it. And our patients matter.

SeedingWe seed change by disrupting established

industries. Cross-platform tech integration and cannabis innovation is how we do it.

WellnessSpecialized treatment programs, tailored

cannabis education courses, illness-specific products. We tailor wellness through

diversification - the consumer experience doesn’t end at the point of sale.

Confidential & Proprietary 3

Page 4: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

Aleafia Health at a Glance

Integrated Cannabis Health & Wellness Platform

3

160,000 sq. ft

3,700,000 sq. ft

129,500 kg

109,500 kg

115,000 kg

70,000+

11,500+

$0.10

Cultivation / Extraction Facilites

Greenhouse Cultivation

Outdoor Cultivation

Total Cultivation Capacity

Licensed, Cultivation Capacity

Licensed, Extraction Capacity

Unique Clinic Patients

Active, Registered Medical patients

All-in cash cost pergram to harvest (outdoor facility)

Adult-Use• 4 provincial and 3 retail distribution supply agreements

• International Expansion into Germany and Australia

Medical / Medical Clinics• Canada’s largest network of medical cannabis

clinics with over 70,000 patients

• Medical products currently in market in Australia

Cannabis 2.0• Differentiated product portfolio of new

formats to launch in 2020

• Future CPG brand integrations focused on health and wellness lifestyle products

Confidential & Proprietary 4

Page 5: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,
Page 6: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

v

Five Consecutive Quarters

Record Net Revenue

RECORD

NET REVEN

UE

Q1 - 18 Q2 - 18 Q3 - 18 Q4 - 18 Q1 - 19 Q2 - 19 Q3 - 19 Q4 - 19 Q1 - 20

84644

1,1371,465 1,525

3,839

4,958

6,028

14,596

SG&AIncrease

Cannabis Revenue Gross

Margin

Adjusted EBITDA

Cash

3%

85%

$35M

$6.4M

Confidential & Proprietary 6

Page 7: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

Medical CannabisMedical cannabis products are the core of our business. That means providing our patients with standardized, repeatable medicine, when they need it.

Adult-use CannabisSome health and wellness consumers who want to purchase their products over the counter. That’s why we made Symbl. Because curiosity is the catalyst for discovery and growth.

Sublingual StripsHealth and wellness conscious consumers want novel, discreet form factors. That’s why we now have the exclusive Canadian rights to product the award-winning KIn Slips sublingual strips. .

Products

Continuous product innovation, powered by research, experience and consumer brand feedback to scale globally

Confidential & Proprietary 7

Page 8: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

Health & Wellness Ecosystem

Virtual ConsultationMedical patients visit our clinic network including partner clinics for physician-led cannabinoid therapy.

9am

12pm

8pm

Secure Online OrderingFollowing prescription, patients seemlessly make their product order through our Emblem medical e-commerce platform.

Direct-to-Door DeliveryMedical cannabis home delivery offered in the Greater Toronto Area exclusively for registered Emblem patients. Discrete and convenient.

Confidential & Proprietary 8

Page 9: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

CultivationFacilities

NiagaraGreenhouse facility featuring modern, perpetual harvest system. It yields standardized, low-cost cannabis flower and secures stable inventory management.

Aleafia Health’s integrated production ecosystem features low-cost cultivation, high-margin processing and high barriers to entry.

ParisEntirely dedicated to the extraction, processing and packaging of value-added cannabis products. Purpose built to EU-GMP requirements.

Port Perry86 acre outdoor cultivation site producing ultra low-cost input material for cannabis products.

Confidential & Proprietary 9

Page 10: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

Port Perry

26-Acre expansion to 86 acres in Licensed May 2020

$0.10 All-in cash cost per gram

• Produced ~13,000 kgs of dried flower in 2019 on 13 acres

• Expansion to total of 86 acres in 2020

Confidential & Proprietary 10

Page 11: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

Niagara Greenhouse

Licensed on March 13, 2020

160,000 sq. ft.

• Ultra modern design and built right-sized to preserve capital

• Acts as staging ground for outdoor cultivation, producting starter plants and handling post harvest

Confidential & Proprietary 11

Page 12: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

Paris Facility

20,000 sq. ft. expansion licensed May 2020

Cannabis 2.0 Innovation• Paris Facility to produce new product

formats including sublingual strips, candies and other derivative formats

• Expands annual extraction capacity to 115,000 kgs of dried flower annually

Confidential & Proprietary 12

Page 13: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

Global Distribution

Canada (Paris Ontario)• Aleafia Health’s global production centre,

the Paris Facility produces medical cannabis products for distribution globally

Germany• Joint-venture with pharmaceutical wholesaler Acnos

Pharma, offering distribution to 20,000 pharmacies

• Exports to commence pending EU-GMP Certification, with application submitted in May 2020

Australia• Products available in market in Australia today

with multiple exports already completed

• 10% equity stake in Australian cannabis producer CannaPacific

Confidential & Proprietary 13

Page 14: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

Health & Wellness Services

TelemedicineVirtual clinic services conducted 100% remotely, offering unparalled scale, convenience and efficiency

70,000+ Patients Seen to Date...All Patient data monitored, from scripting, diagnosis, to purchasing

Cannabinoid Therapy ExpertiseFocus on pain, anxiety, eating disorders, pediatrics, autism, palliative care and epilepsy.

Global Medical Cannabinoid Therapy Expertise

Proprietary patient on-boarding, diagnosing and treatments tuned over 5+ years across hundreds of thousands of patient engagements.

Confidential & Proprietary 14

Page 15: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

Trevor NewellChief Marketing & Technology Officer

President at Wholesale Energy Systems and was the Co-Founder and President at SHOP.ca Network Inc.

Benjamin FerdinandChief Financial OfficerPreviously served as Managing Director, Platform Strategies and VP, Head of Finance, Strategy and Corporate Development at the TMX Group

Greg Rossi Chief Operating Officer

Executive consultant on supply chain logistics at Walmart, Campbell, Kraft Heinz, Nestle, Mondelez. Founding partner of Grocery Gateway.

“By seeking a new form of care, our patients have the courage to do things differently. They are our inspiration, and that differentiation our mantra.”

Past senior leadership experience as Founder & Chairman at Sofilia Logistics Group; General Manager at Grocery Gateway; Regional Director, UPS Canada.

Executive consultant on supply chain logistics at Walmart, Campbell, Kraft Heinz, Nestle, Mondelez.

Geoff Benic / Chief Executive Officer

Geoff BenicChief Executive Officer

Management Team

Dr. Michael Verbora Chief Medical Officer

Physician at Department of Family Medicine, University of Toronto. 5000+ Cannabinoid therapy consultations.

Keith WhitePresident of Clinics

Previously served as Chief Operating Officer at Oshawa Clinic Group, Canada’s largest multidisciplinary clinic network.

Confidential & Proprietary 15

Page 16: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

“Trust and accountability are paramount. To our team, to our shareholders, and to our patients.”

Board of Directors

Loreto GrimaldiServed as Executive Vice President and Chief Legal Officer of Progressive Waste Solutions

Lea RayHas held multiple board leadership positions including Workplace Safety and Insurance Board, Street Capital Group

Rhonda LawsonDistinguished independent director of for profit and not-for-profit boards. Experienced healthcare and insurance executive.

Mark SandlerSenior Partner at Cooper, Sandler, Shine & Bergman

Daniel Milliard CEO of Indian River Consulting Inc. General Manager of Islip Flow Controls,, Director, Progressive Waste Solutions

Glenn WasherBiotechnology and pharmaceuitcal executive. Most rcently President of Charles River Laboratories Montreal ULC.

Confidential & Proprietary 16

Page 17: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

SHAREHOLDER INFORMATION

Ticker Symbol:TSX / ALEF

Registrar and Transfer AgentComputershare Ltd. Vancouver510 Burrard St, 3rd FloorVancouver, BC V6C 3B9t / 1 -800-564-6253

AuditorsManning Elliott LLP

INVESTOR CONTACTS

t / 1 -833-TSX-ALEF (879-2533)e / [email protected]

Nicholas BergaminiVP, Investor Relations

DIRECTORLea Ray

DIRECTORLoreto Grimaldi

DIRECTORDaniel Milliard

DIRECTORRhonda Lawson

DIRECTORMark Sandler

DIRECTORGlenn Washer

CHIEF EXECUTIVE OFFICERGeoffrey Benic

CHIEF FINANCIAL OFFICERBenjamin Ferdinand

CHIEF OPERATING OFFICERGreg Rossi

CHIEF MARKETING & TECHNOLOGY OFFICERTrevor Newell

CHIEF MEDICAL OFFICERDr. Michael Verbora

PRESIDENT OF CLINIC OPERATIONSKeith White

Corporate Directory

17Confidential & Proprietary

Page 18: 2020 Q1 CORPORATE PRESENTATION - aleafiahealth.com · 2020 Q1 CORPORATE PRESENTATION ... Certain statements herein relating to the Company constitute “forward looking statements”,

AleafiaHealth.com